Cours suspendu
Dividendes sectoriels Apellis Pharmaceuticals, Inc.
Actions
APLS
US03753U1060
Produits pharmaceutiques
|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 41,03 USD | -0,07% |
|
-.--% | +63,34% |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Rendement du dividende (N) | Rendement du dividende (N+1) | PER (N) | Price to Book (N) | VE / CA (N) | VE / EBITDA (N) | VE / EBIT (N) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | 5,25 Md | |
| 0,58% | 0,66% | 17.76x | 2.02x | 3.85x | 10.09x | 11.52x | 68,85 Md | |
| 0,61% | 0,63% | 25.64x | 3.88x | 5.3x | 15.59x | 19.32x | 52,13 Md | |
| -.--% | -.--% | 34.55x | 6.94x | 11.7x | 22.35x | 26.04x | 43,46 Md | |
| 3,31% | 3,4% | -46.16x | 2.53x | 3.26x | 9.62x | 11.22x | 41,24 Md | |
| -.--% | -.--% | 24.47x | 1.63x | 3.57x | 11.94x | 13.55x | 30,41 Md | |
| -.--% | -.--% | -7.13x | 4.33x | 10.08x | -6.19x | -5.82x | 24,53 Md | |
| -.--% | -.--% | 41.9x | - | - | - | - | 23,42 Md | |
| -.--% | 0,05% | 64.32x | 5.78x | 6.31x | 43.41x | 48.98x | 19,75 Md | |
| -.--% | -.--% | 24.47x | 3.59x | 5.19x | 13.62x | 18.87x | 16,57 Md | |
| -.--% | -.--% | -36.62x | -6.49x | 17.52x | -47.76x | -54.5x | 15,95 Md | |
| -.--% | -.--% | -111.49x | 12182.2x | 11.98x | -85.75x | -119.56x | 11,84 Md | |
| -.--% | -.--% | 17.66x | - | 3.62x | 14.01x | 16.36x | 11,52 Md | |
| -.--% | -.--% | 46.82x | - | - | - | - | 10,46 Md | |
| 0,18% | 0,19% | 50.59x | 20.63x | 30.53x | 43.18x | 44.53x | 9,96 Md | |
| 2,86% | 3,24% | 11.97x | 1.08x | 1.81x | 7.29x | 9.85x | 6,28 Md | |
| 0,37% | 0,44% | 27.66x | - | 7.41x | 19.67x | 23.5x | 5,64 Md | |
| -.--% | -.--% | -108.47x | - | - | - | - | 5,33 Md | |
| Moyenne | 0,47% | 0,51% | 4,59x | 1 019,01x | 8,72x | 5,08x | 4,56x | 22,37 Md | |
| Moyenne pondérée par Capi. | 0,58% | 0,61% | 10,90x | 426,35x | 7,18x | 8,77x | 9,74x |
- Bourse
- Actions
- Action APLS
- Secteur Apellis Pharmaceuticals, Inc.
- Dividendes sectoriels
Choisissez Zonebourse Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
